Bridgeway Capital Management’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
59,326
-63,706
| -52% | -$189K | ﹤0.01% | 985 |
|
|
2025
Q1 | $399K | Sell |
123,032
-21,598
| -15% | -$70K | 0.01% | 783 |
|
|
2024
Q4 | $571K | Sell |
144,630
-2,962
| -2% | -$11.7K | 0.01% | 783 |
|
|
2024
Q3 | $1.14M | Sell |
147,592
-6,586
| -4% | -$50.9K | 0.02% | 648 |
|
|
2024
Q2 | $792K | Buy |
154,178
+4,860
| +3% | +$25K | 0.02% | 749 |
|
|
2024
Q1 | $1.21M | Buy |
149,318
+4,725
| +3% | +$38.4K | 0.02% | 691 |
|
|
2023
Q4 | $578K | Buy |
144,593
+5,352
| +4% | +$21.4K | 0.01% | 903 |
|
|
2023
Q3 | $574K | Buy |
139,241
+12,565
| +10% | +$51.8K | 0.01% | 841 |
|
|
2023
Q2 | $752K | Buy |
126,676
+12,336
| +11% | +$73.3K | 0.02% | 798 |
|
|
2023
Q1 | $394K | Sell |
114,340
-9,060
| -7% | -$31.3K | 0.01% | 939 |
|
|
2022
Q4 | $433K | Sell |
123,400
-9,600
| -7% | -$33.7K | 0.01% | 915 |
|
|
2022
Q3 | $481K | Buy |
133,000
+102,500
| +336% | +$371K | 0.01% | 904 |
|
|
2022
Q2 | $172K | Buy |
+30,500
| New | +$172K | ﹤0.01% | 1124 |
|
|
2020
Q3 | – | Sell |
-22,300
| Closed | -$306K | – | 1366 |
|
|
2020
Q2 | $306K | Buy |
+22,300
| New | +$306K | 0.01% | 1032 |
|